• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2021.16030

Helicobacter pylori as a risk factor for the development of metabolic syndrome and gallstone disease

[T h e r a p y]
Andrey Svistunov; Mikhail Osadchuk; Ekaterina Dmitrievna Mironova; Inna Nikolaevna  Vasil’eva;

To study the Helicobacter pylori (H. pylori) effect on gallstone disease development and metabolic syndrome (MetS) and its components, the main factors of biliary stone formation. The study included 143 patients with cholelithiasis, of which 88 (61.5 %) were infected with H. pylori and 55 (38.5 %) were not. All subjects were assessed for MetS and its components` severity. A high prevalence of metabolic disorder and MetS was revealed in patients with H. pylori. The results obtained suggest that H. pylori promotes gallbladder calculi development by affecting patients` metabolic profile.

Download

References:
1. Rodriguez S., Gaunt T. R., Guo Y., Zheng J., Barnes M. R. [et al.] Lipids, obesity and gallbladder disease in women: Insights from genetic studies using the cardiovascular gene-centric 50K SNP array. European journal of human genetics: EJHG. 2015;24:106-112. https://doi.org/10.1038/ejhg.2015.63
2. Cen L., Pan J., Zhou B., Yu C., Li Y. [et al.] Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis. Helicobacter. 2018;23(1). https://doi.org/10.1111/hel.12457
3. Zhou D., Zhang Y., Gong W., Mohamed S. O., Ogbomo H. [et al.] Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis. PLoS One. 2011;6(11):e27390. https://doi.org/10.1371/journal.pone.0027390
4. Chang W.-L., Yeh Y.-C., Sheu B.-S. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J. Biomed. Sci. 2018;25. https://doi.org/10.1186/s12929-018-0466-9
5. Jeyamani L., Jayarajan J., Leelakrishnan V., Swaminathan M. CagA and VacA genes of Helicobacter pylori and their clinical relevance. Indian J. Pathol. Microbiol. 2018;61(1):66-69. https://doi.org/10.4103/IJPM.IJPM_234_17
6. Upala S., Jaruvongvanich V., Riangwiwat T., Jaruvongvanich S., Sanguankeo A. Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis. J. Dig. Dis. 2016;17(7):433-440. https://doi.org/10.1111/1751-2980.12367
7. Pradhan S. B. Study of Helicobacter hepaticus in gallbladders with cholelithiasis and its sensitivity pattern. Kathmandu Univ. Med. J. (KUMJ). 2009;7:125-128. https://doi.org/10.3126/kumj.v7i2.2704
8. Yonezawa H., Osaki T., Hojo F., Kamiya S. Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin. Microb. Pathog. 2019;132:100-108. https://doi.org/10.1016/j.micpath.2019.04.030
9. Madsen J. S., Burmølle M., Hansen L. H., Sørensen S. J. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. Microbiol. 2012;65(2):183-195. https://doi.org/10.1111/j.1574-695X.2012.00960.x
10. Wong E. H., Ng C. G., Chua E. G., Tay A. C., Peters F. [et al.] Comparative Genomics Revealed Multiple Helicobacter pylori Genes Associated with Biofilm Formation In Vitro. PLoS One. 2016;11(11):e0166835. https://doi.org/10.1371/journal.pone.0166835
11. Wei J., Noto J. M., Zaika E., Romero-Gallo J., Piazuelo M. B. [et al.] Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut. 2015;64(7):1040-1048. https://doi.org/10.1136/gutjnl-2014-307295
12. Li N., Tang B., Jia Y. P., Zhu P., Zhuang Y. [et al.] Helicobacter pylori CagA Protein Negatively Regulates Autophagy and Promotes Inflammatory Response via c-Met-PI3K/Akt-mTOR Signaling Pathway. Front. Cell. Infect. Microbiol. 2017;7:417. https://doi.org/10.3389/fcimb.2017.00417
13. Wunder C., Churin Y., Winau F., Warnecke D., Vieth M. [et al.] Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med. 2006;12(9):1030-1038. https://doi.org/10.1038/nm1480
14. Altuntaş Y., Batman A. Microbiota and metabolic syndrome. Turk Kardiyol. Dern. Ars. 2017;45(3):286-296. https://doi.org/10.5543/tkda.2016.72461
15. Tsai H.-F., Hsu P.-N. Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathology. Cell. Mol. Immunol. 2010;7(4):255-259. https://doi.org/10.1038/cmi.2010.2
16. Chen L.-W., Kuo S.-F., Chen C.-H., Chien C.-H., Lin C.-L. [et al.] A community-based study on the association between Helicobacter pylori Infection and obesity. Sci. Rep. 2018;8(1):10746. https://doi.org/10.1038/s41598-018-28792-1
17. Diomedi M., Pietroiusti A., Silvestrini M., Rizzato B., Cupini L. M. [et al.] CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke. Neurology. 2004;63(5):800-804. https://doi.org/10.1212/01.wnl.0000138025.82419.80
18. Wan Z., Hu L., Hu M., Lei X., Huang Y. [et al.] Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults. J. Hum. Hypertens. 2018;32(2):158-164. https://doi.org/10.1038/s41371-017-0028-8
19. Hoffmeister A., Rothenbacher D., Bode G., Persson K., März W. [et al.] Current Infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumonia or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler. Thromb. Vasc. Biol. 2001;21(3):427-432. https://doi.org/10.1161/01.atv.21.3.427
20. Gunji T., Matsuhashi N., Sato H., Fujibayashi K., Okumura M. [et al.] Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am. J. Gastroenterol. 2008;103(12):3005-3010. https://doi.org/10.1111/j.1572-0241.2008.02151.x
21. Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M. [et al.] Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 1999;142(1):207-210. https://doi.org/10.1016/s0021-9150(98)00194-4
22. Pohjanen V.-M., Koivurova O.-P., Niemelä S. E., Karttunen R. A. [et al.] Role of Helicobacter pylori and interleukin 6–174 gene polymorphism in dyslipidemia: a case-control study. BMJ Open. 2016;6(1):e009987. https://doi.org/10.1136/bmjopen-2015-009987
23. Bahadoran Z., Mirmiran P., Zarif-Yeaganeh M., Zojaji H., Azizi F. Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients. Endocrinol. Metab. (Seoul). 2015;30(3):280-287. https://doi.org/10.3803/EnM.2015.30.3.280
24. Osadchuk M. A., Mironova E. D., Vasileva, I. N., Korzhenkov N. P., Achkasov E. E. [et al.] Oral medical dissolution of gallstones in patients with gallstone disease. Pren. Méd. Argent. 2019;1:34-40.
25. Lai C. H., Chang Y. C., Du S. Y., Wang H. J., Kuo C. H. [et al.] Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect. Immun. 2008;76(7):3293-3303. https://doi.org/10.1128/IAI.00365-08

Keywords: gallstone disease, helicobacter pylori, metabolic syndrome